
|Videos|May 4, 2020
Biologic use in the era of COVID-19
Author(s)Jessica Barry
This week, we spoke with Mark Lebwohl, M.D., about his recent article featured in the Journal of the American Academy of Dermatology regarding biologic use in dermatology patients during the COVID-19 pandemic.
Advertisement
This week, we spoke with Mark Lebwohl, M.D., Waldman Professor and Chair, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, about his recent article featured in the Journal of the American Academy of Dermatology regarding biologic use in dermatology patients during the COVID-19 pandemic.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clinique's Daily Calm Merges Clinical Efficacy with Color Cosmetics for Sensitive Skin
2
Chronic Hand Eczema: Treatment Gaps, New Options, and Clinical Trial End Points
3
Clear Health Launches Topical Isotretinoin Acne Treatment Without iPLEDGE Requirements
4
Topical DB-006 Shows Strong Efficacy, Safety in Preclinical AD Model
5













